title: Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.
authors.forename: Estrella
authors.initials: E
authors.lastname: Garcia-Gonzalez
authors.forename: Giacomo M
authors.initials: GM
authors.lastname: Guidelli
authors.forename: Marco
authors.initials: M
authors.lastname: Bardelli
authors.forename: Roberta
authors.initials: R
authors.lastname: Maggio
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D015153:Blotting, Western; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D019084:Fluorescent Antibody Technique, Indirect; D006801:Humans; D018314:Leishmania infantum / Q000302:isolation & purification*; D007897:Leishmaniasis, Mucocutaneous / Q000175:diagnosis* / Q000209:etiology / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology / Q000473:pathology; D013167:Spondylitis, Ankylosing / Q000188:drug therapy*; D014057:Tomography, X-Ray Computed
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab; D008775:Methylprednisolone; D008727:Methotrexate